ALEXANDRIA, Va. – The American Society of Clinical Oncology (ASCO) announced today the appointment of David Kerr, MD, DSc, as founding Editor-in-Chief of the Society’s new Journal of Global Oncology (JGO). Prof. Kerr will set the editorial scope and vision for JGO, an online-only, open-access journal that will focus on cancer care, research, and care delivery issues unique to countries and settings with limited healthcare resources.
It is estimated that today nearly two-thirds of all cancer deaths occur in low- and middle-income countries (LMICs), and this is forecast to increase to 70 percent by 2030.  While some journals publish special issues and sections focused on global oncology, currently there are no journals solely dedicated to this area of research. The inaugural issue of JGO will publish later this year and feature high-quality original research, editorials, and other articles that address the unique challenges of cancer care and research in LMICs.
“The Journal of Global Oncology will fulfill a growing need in clinical oncology literature by providing a peer-review platform for authors to publish research on the array of challenges that low- and middle-income countries face in conducting research and caring for patients with cancer,” said ASCO President Peter Paul Yu, MD, FASCO. “Prof. Kerr’s distinguished oncology career and expertise in the international research community are valuable assets to this exciting new project, and we are thrilled to have his leadership to help guide the journal’s launch.”
Prof. Kerr is a Professor of Cancer Medicine at the University of Oxford, an Honorary Consultant Medical Oncologist at Oxford University Hospitals Trust, and an Adjunct Professor of Medicine at Weill Cornell Medical College. He is a past president of the European Society of Medical Oncology and has served on numerous medical society international committees and working groups. Prof. Kerr co-founded the Africa Oxford Cancer Foundation and has also fostered international collaborations with organizations around the world that share the goal of improving cancer research and care.
“There is a growing need for high-quality clinical cancer research in low- and middle-income countries, and I am honored to support the Society’s vision to help improve cancer care and delivery in these areas,” said Prof. Kerr.
Prof. Kerr brings a wealth of expertise to the position. He has published countless peer-reviewed articles on colorectal cancer, drug development, gene therapy, and general medicine. He has served on the editorial boards of several prestigious oncology journals including the Annals of Oncology (former Editor-in-Chief), Nature Clinical Oncology Reviews, Japanese Journal of Clinical Oncology, Seminars in Oncology, Molecular Oncology, and Chinese Clinical Oncology.
Prof. Kerr is a Fellow of the Royal Colleges of Physicians, Honorary Fellow of the Royal College of General Practitioners, Fellow of the Academy of Medical Sciences, and Fellow of the European Academy of Cancer Sciences.
The Journal of Global Oncology is funded through the Conquer Cancer Foundation of the American Society of Clinical Oncology with the support of the Conquer Cancer Foundation Mission Endowment, the Doris Duke Charitable Foundation and Novartis Oncology.
For inquiries regarding the Journal of Global Oncology, including submission information, please contact JGO@asco.org.
Founded in 1964, the American Society of Clinical Oncology (ASCO) is the world’s leading professional organization representing physicians who care for people with cancer. With more than 35,000 members, ASCO is committed to improving cancer care through scientific meetings, educational programs and peer-reviewed journals. ASCO is supported by its affiliate organization, the Conquer Cancer Foundation, which funds groundbreaking research and programs that make a tangible difference in the lives of people with cancer. For ASCO information and resources, visit asco.org. Patient-oriented cancer information is available at Cancer.Net.